Once again, most of the work regarding ARID1A focuses on its function in transcription, but several studies have shown that this subunit is also important for the repair of DSBs, thus ARID1A-mutated cancers likely have a DNA repair vulnerability that can be exploited therapeutically. The gene discussed is ARID1A; the disease is cancer.